Power morcellator litigation
Litigation alleged that laparoscopic morcellation, which minces tissue for removal through small incisions, spread undetected uterine cancer throughout the abdomen.
Free case review
What the litigation alleged
When a presumed-benign fibroid is actually a hidden sarcoma, morcellating it can scatter malignant tissue. The FDA warned against the practice in 2014 and the leading manufacturer withdrew its devices. Claims alleged women were never told the screening for hidden cancer was unreliable.
Injuries named in the litigation
- Upstaged leiomyosarcoma after morcellation
- Disseminated uterine cancer
- Reduced survival from seeded tumors
Who may qualify
If you or a family member had fibroid surgery with morcellation and were subsequently diagnosed with disseminated uterine cancer, you may have a claim. The review is free and confidential, and we will give you an honest answer either way. You pay attorney's fees only if we recover for you.
Call (888) 391‑1315 or use the form for a free, confidential review. You pay attorney's fees only if we recover for you.